22/12/2014 04:11:35 Free Membership Login

   

AVANIR Pharmaceuticals

Visual Financials
Company Name: AVANIR Pharmaceuticals
Ticker Symbol: AVNR
WWW Address: http://www.avanir.com
CEO: Keith Katkin
No. of Employees: 267
Common Issue Type: CS
Business Description:Avanir Pharmaceuticals is a biopharmaceutical company engaged in acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders.

 
Industry Information: DRUGS - Drugs - Generic [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 16.85 Unchanged 0.0 16.92 16.96  16.98 16.84 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 3,264.8 193.8 0.00 -0.31 0.00 0.0 0.0 17.05 - 2.87
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close16.85$
PE Ratio - LTM0.0
Market Capitalisation3,264.8mil
Latest Shares Outstanding193.8mil
Earnings pS (EPS)-0.31$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float112.1mil
Float as % of Shares Outstanding0.6%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue1.00%
Research & Devlopment (R&D) as % of Revenue0.40%
Gross Profit Margin96.9%
EBITDA Margin-39.7%
Pre-Tax Profit Margin-43.8%
Assets Turnover60.1%
Return on Assets (ROA)-26.3%
Return on Equity (ROE)-34.6%
Return on Capital Invested (ROCI)-29.3%
Current Ratio9.4
Leverage Ratio (Assets/Equity)1.1
Interest Cover-14.2
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Total Capital0.0%
Working Capital pS1.39$
Cash pS0.00$
Book-Value pS1.41$
Tangible Book-Value pS1.41$
Cash Flow pS-0.30$
Free Cash Flow pS-0.32$
KEY FIGURES (LTM): Price info
Price/Book Ratio11.95
Price/Tangible Book Ratio0.00
Price/Cash Flow-55.9
Price/Free Cash Flow-52.6
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---17.054.01431
4 Weeks16.9816.8416.8417.054.011754
13 Weeks16.8516.851248523613.5017.051754
26 Weeks1248523617.0517.0513.5717.051725
52 Weeks13.7613.7613.8817.052.651425
YTD2.872.87-17.053.02397
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
10.3810.3811.0411.0417.050.230.23
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue2185912449158912791589127
Income218591244218591244415329960
Dividend415329960679426077679426077
Capital Spending1008445616NA1008445616
R&D206916153NA206916153
Normalized Inc.415329960NA415329960
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %208312312
Earnings %475475418
EPS %187155155
EPS $418126126
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio306983000
Quick Ratio (Acid Test)6166000
Liquidity Ratio (Cash)0.00
Receivables Turnover
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS273389000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)6724000
Debt Ratio33594000
Total Debt/Equity (Gearing Ratio)FI
LT Debt/Equity
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities33594000
Interest Cover-4753000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM680,649,235.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow-269.97
Dividend Yield48979355
Price/Tangible Book Ratio - LTM163
Price/Book Ratio - LTM4003351
Price/Cash Flow Ratio9.4
Price/Free Cash Flow Ratio - LTM163
Price/Sales Ratio12.00
P/E Ratio (1 month ago) - LTM680649235
P/E Ratio (26 weeks ago) - LTM869818870
P/E Ratio (52 weeks ago) - LTM869818870
5-Y High P/E Ratio1012847885
5-Y Low P/E Ratio987035437
5-Y Average P/E Ratio8136484
Current P/E Ratio as % of 5-Y Average P/E8136484
P/E as % of Industry Group10,929,562.0
P/E as % of Sector Segment10,929,562.0
Current 12 Month Normalized P/E Ratio - LTM8,326,284.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM9.4
Book Value pS - LTM4003351
Capital Invested pS0.00
Cash pS - LTM61139
Cash Flow pS - LTM10.13
Free Cash Flow pS - LTM10.13
Earnings pS (EPS)-68
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-4753000
Net Profit Margin - 5YEAR AVRG.2014-12-01
Equity Productivity0.00
Return on Equity (ROE)273389000
Return on Equity (ROE) - 5YEAR AVRG.3264834145
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-96
Assets Productivity6,724,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.3264834145
Gross Profit Margin10929562
Gross Profit Margin - 5YEAR AVRG.-96
EBITDA Margin - LTM6389691
EBIT Margin - LTM10929562
Pre-Tax Profit Margin3631000
Pre-Tax Profit Margin - 5YEAR AVRG.193758703
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle32,094,161
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover
Day's Inventory Turnover Ratio32093000
Inventory Turnover
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover6724000
Revenue per $ Cash25369000
Revenue per $ Plant25369000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.193758703
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq avnr141222 04:11